Mount Sinai researchers develop tool to determine function of MicroRNAs
As microRNA biology has been implicated in everything from the development of cancer to virus infections, a new tool developed by scientists at the Icahn School of Medicine at Mount Sinai holds tremendous potential to develop new therapies that involve these small regulatory fragments of RNA. While the article focuses on microRNA function as it pertains to virus infection, the development and characterization of this new tool has implications that far exceed the field of microbiology.
"Apart from their roles in causing medical maladies, viruses have long been used as tools to reveal unappreciated aspects of biology, providing us with insights into the many unknowns of how our cells function," said Benjamin tenOever, PhD, Fishberg Professor of Microbiology at the Icahn School of Medicine at Mount Sinai and corresponding author of the study. "We developed a tool based on a poxvirus gene that allows us to manipulate microRNA populations in any tissue or cell type we desire".
With the capacity to fine-tune protein expression, microRNAs, also called miRNAs, help regulate cell maintenance and differentiation. This regulatory pathway is known to often malfunction in the development of cancer and its role in the response to virus infection has remained largely unknown and difficult to study. To determine the global role of miRNAs in both cell biology and the response to virus infection, the team at Mount Sinai, led by Dr. tenOever and PhD candidate Lauren C. Aguado, designed and generated a synthetic vector that rapidly eliminates total cellular miRNA populations in any cell or tissue to which it was administered.
While loss of miRNAs had a negligible impact on the cell's immediate reaction to virus or the short term biology of the cell, sustained depletion was found to have dramatic results on gene expression that was coupled to a burst of cytokines - protein messengers that alert the immune system of a problem. In all, this work concludes that miRNA function is limited to modulating the biology of the cell over long periods of time. Having a tool that can now manipulate these responses provides us with an unprecedented platform to reprogram healthy cells or treat diseases such as cancer where these pathways have malfunctioned.
Original publication
Lauren C. Aguado, Sonja Schmid, David Sachs, Jaehee V. Shim, Jean K. Lim, Benjamin R. tenOever; "microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection"; Cell Host & Microbe; 2015
Original publication
Lauren C. Aguado, Sonja Schmid, David Sachs, Jaehee V. Shim, Jean K. Lim, Benjamin R. tenOever; "microRNA Function Is Limited to Cytokine Control in the Acute Response to Virus Infection"; Cell Host & Microbe; 2015
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

New insight into the maturation of miRNAs
Eurofins to acquire EAG Laboratories - Expanding its presence in North America
Aquapharm and Dundee University Sign Research Collaboration to find Marine Compounds to target Alzheimer’s

Nanomedicines on their way through the body - Which pathways do nanomedicines take after they have been swallowed?
Bavarian Nordic receives USD 25 million milestone payment after submission of IMVAMUNE data to the U.S. Health Authorities

Cellular contamination pathway for plutonium, other heavy elements, identified - Scientists find that an iron-binding protein can transport actinides into cells
Salmon genome in final phases of completion
Lundbeck expands the agreement with Teva to include marketing of Azilect in selected Asian countries
Novartis data shows ACZ885 for severe gouty arthritis provided better pain relief and reduced risk of new attacks by up to 68% vs. steroid - Two pivotal Phase III studies showed ACZ885 may meet significant unmet need for patients for whom many standard therapies are inadequate or inappropriate

Breakthrough in mapping nicotine addiction could help researchers improve treatment

Study shows how bioactive substance inhibits important receptor - Results from the University of Bonn raise hope for new drugs against cancer and brain diseases
